Database for Parkinson's Disease and Related Disorders
Official title: Parkinson's Disease and Movement Disorders Clinical Database
Run by University of Pennsylvania · NCT04997642 · Data updated 2026-11-12
This study is creating a detailed database of information from people with Parkinson's disease to help researchers understand how the disease progresses and how different treatments work over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | University of Pennsylvania Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Status | Recruiting |
| Started | September 30, 2019 |
| Main results expected | September 15, 2029 |
| Study ends | September 15, 2029 |
| Registry record updated | October 13, 2026 |
| Trial ID | NCT04997642 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals diagnosed with Parkinson's disease who may also have mild cognitive impairment or dementia.
✕Probably not a fit
Patients without a diagnosis of Parkinson's disease will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study creates a comprehensive research database that includes demographic and family history information, clinical symptoms, neuropsychological profiles, treatments, biological samples, and brain images of patients with Parkinson's disease and related disorders. Participants are seen annually for the first four years and biennially thereafter, allowing for longitudinal analysis of the disease's progression and treatment effects. The database aims to facilitate research on the long-term effects of Parkinson's disease, identify genetic factors, and improve patient management strategies.
Why it matters
Potential benefit: If successful, this database could enhance understanding of Parkinson's disease and lead to improved treatment and management strategies for patients.
How similar studies have gone: Other studies utilizing similar observational databases have shown success in advancing understanding and treatment of neurodegenerative diseases.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Any person who receives medical care for the diagnosis of Parkinson's disease with mild cognitive impairment (MCI) or dementia may be eligible to participate in the research database. There are no limitations for database participation based on age, disease severity or presence of cognitive impairments, as long as the person is able to complete the research assessments. Exclusion Criteria: Absence of Parkinson's disease diagnosis. There are no limitations for database participation based on age, disease severity or presence of cognitive impairments, as long as the person is able to complete the research assessments.
Where it's running
-
University of Pennsylvania
Philadelphia, Pennsylvania, United States Recruiting
Study contacts
- Study coordinator: Eugenia Mamikonyan
- Email: eugenia.mamikonyan@pennmedicine.upenn.edu
- Phone: 215-615-3085
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
MAO-B PET/CT imaging in Parkinson’s-related diseases
This study tests whether 18F-FPyCO/SMBT-1 PET/CT can help diagnose Parkinson’s-related conditions by measuring lesion uptake in patients with PD, PD dementia, or parkinsonism.
-
Tributyrin for memory, thinking, and walking problems in Parkinson's disease
This trial will test whether taking tributyrin three times a day for about 80–100 days helps memory, thinking, walking, and balance in adults with Parkinson's disease or Parkinson disease dementia, and will monitor safety.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.